RFG Advisory, LLC

Position in PRQR — ProQR Therapeutics N.V.

CIK 1633387 BIRMINGHAM, AL

Position in PRQR

as of Jun 30, 2026 · filed Jul 15, 2026 Compact

Position Value

$119,040

+$88,260 QoQ

Shares Held

64,000

+236.8% QoQ

Ownership

0.045%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

of 1 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Jun 30, 2026

RFG Advisory, LLC holds $11,845,532 across 11 Biotechnology names. PRQR ranks #7 (1.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VKTX	Viking Therapeutics, Inc.	142,790	$5,570,237
2	CPRX	Catalyst Pharmaceuticals, Inc.	85,989	$2,702,634
3	HALO	Halozyme Therapeutics, Inc.	19,613	$1,535,109
4	VRTX	Vertex Pharmaceuticals Inc / Ma	1,989	$987,995
5	REGN	Regeneron Pharmaceuticals, Inc.	789	$491,973
6	INCY	Incyte Corp	2,120	$240,323
7	PRQR	ProQR Therapeutics N.V. This page	64,000	$119,040
8	ABVX	Abivax S.A.	643	$85,686

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$119,040	64,000	+236.8%	Shares	Sole	2026-07-15
2026-03-31	$30,780	19,000	-36.7%	Shares	Sole	2026-04-20
2025-12-31	$60,600	30,000	0.0%	Shares	Sole	2026-02-03
2025-09-30	$63,900	30,000	0.0%	Shares	Sole	2025-11-06
2025-06-30	$61,200	30,000	0.0%	Shares	Sole	2025-07-28
2025-03-31	$39,900	30,000	0.0%	Shares	Sole	2025-04-09
2024-12-31	$79,500	30,000	-28.6%	Shares	Sole	2025-01-21
2024-09-30	$76,440	42,000	+31.2%	Shares	Sole	2024-10-17
2024-06-30	$53,120	32,000	0.0%	Shares	Sole	2024-07-15
2024-03-31	$73,280	32,000	—	Shares	Sole	2024-04-11
No filing history on record for this holder in this stock.